KLK3 and Familial prostate cancer: In current clinical practice, the limitations of the PSA-blood-test are being addressed by performing multi-parametric magnetic resonance imaging (MRI) before biopsies to decrease the detection of non-significant prostate cancer and to improve the detection of significant prostate cancer (49, 50).